Dec 30, 2025 04:06PM KORU Medical submits FDA application for cancer drug infusion system

Nov 13, 2025 02:10AM Canaccord Genuity Reiterates Buy Rating on Koru Medical Systems Inc. (KRMD)

Nov 12, 2025 04:28PM Repro Med Systems (KRMD) Tops Q3 EPS by 2c, raises guidance

Sep 18, 2025 08:15AM ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Aug 6, 2025 05:07PM Repro Med Systems (KRMD) Tops Q2 EPS by 3c ; Offers Guidance

Jul 7, 2025 04:05PM KORU Medical names Adam Kalbermatten as chief commercial officer

Jun 11, 2025 04:05PM KORU Medical Systems (KRMD) to Join Russell 3000 and Russell 2000 Indexes

May 7, 2025 04:45PM Repro Med Systems (KRMD) Tops Q1 EPS by 3c, provides guidance

Mar 12, 2025 04:10PM Repro Med Systems (KRMD) Tops Q4 EPS by 1c ; Offers Guidance

Feb 14, 2025 04:11AM Piper Sandler Downgrades Koru Medical Systems Inc. (KRMD) to Neutral

Jan 30, 2025 04:06PM Repro Med Systems (KRMD) Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Jan 17, 2025 08:59AM Koru Medical Systems Inc. (KRMD) PT Raised to $6 at Craig-Hallum

Jan 14, 2025 04:06PM Repro Med Systems (KRMD) Reports Prelim Q4 Results

Jan 14, 2025 06:37AM Canaccord Genuity Reiterates Buy Rating on Koru Medical Systems Inc. (KRMD)

Jan 13, 2025 08:11AM Repro Med Systems (KRMD) Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

Nov 14, 2024 07:19AM Koru Medical Systems Inc. (KRMD) PT Raised to $3.50 at Piper Sandler

Nov 14, 2024 07:13AM Koru Medical Systems Inc. (KRMD) PT Raised to $4 at Canaccord Genuity

Nov 13, 2024 04:11PM Repro Med Systems (KRMD) Tops Q3 EPS by 3c, provides guidance

Aug 8, 2024 07:39AM Koru Medical Systems Inc. (KRMD) PT Raised to $3 at Piper Sandler

Jul 2, 2024 10:05AM Canaccord Genuity Bullish on Koru Medical Systems Inc. (KRMD)